Practising prioritisation: exploring variation in applying a clinical pharmacy risk stratification toolFiona B McIntyre, Lauren Vickers, Alexandra Wallem, Marianne van de l’Isle, Amanda McLean, Caroline Souter
6 December 2022
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 yearsAlessia Romagnoli, Fiorenzo Santoleri, Alberto Costantini, Angelora Di Risio
12 August 2022
Effect of a smart temperature logger on correctly storing biological disease-modifying antirheumatic drugs at home: a pre-post studyLex L Haegens, Victor J B Huiskes, Charlotte L Bekker, Bart J F van den Bemt
21 February 2024
Switching anti-CGRP monoclonal antibodies in chronic migraine: real-world observations of erenumab, fremanezumab and galcanezumabJamie Talbot, Rebecca Stuckey, Natasha Wood, Alexander Gordon, Ginette Crossingham, Stuart Weatherby
5 January 2024
A qualitative evaluation of weekly reflective practice sessions for the intensive care unit pharmacy team during the COVID-19 pandemicNaima Fowlis, Nina Barnett, Sara Banks, Barry Jubraj
15 April 2022
Medical management of first trimester miscarriage: a quality improvement initiativeDeirdre Hayes-Ryan, Sharon Cooley, Brian Cleary
23 August 2021
Impact of a pharmaceutical intervention on influenza vaccination in patients receiving treatment with biological medicinesLaura Villaverde Piñeiro, Ana Isabel Cachafeiro Pin, Yveth Michelle Tajes González, Pilar Neira Blanco, Lorena Arias Fernández, Mónica Vázquez López, Andrés Blanco Hortas, Concepcion Castro Rubiños, José Vicente Aparici Bolufer
31 March 2022
Infliximab: a single-centre, prospective, observational evaluation of TDM data in patients with IBDJessica Gadsby, Karen Hall, Fathima Shah, Sanjeev Pattni, Sharon Gethins, Hussain Mulla
25 February 2022
Medication adherence reporting in pivotal clinical trials: overview of oral oncological drugsRuggero Lasala, Fiorenzo Santoleri, Alessia Romagnoli, Paolo Abrate, Felice Musicco, Alberto Costantini
20 January 2022
Real-world outcomes of abiraterone and enzalutamide in first-line treatment of metastatic castration-resistant prostate cancer: which patients benefit most?Macarena García Trevijano Cabetas, Miguel Escario-Gómez, Luis González-Del Valle, Carmen Sobrino Jiménez, Cristina Bilbao Gomez-Martino, José Antonio Romero-Garrido, Juana Benedi-González, Enrique Espinosa Arranz, Mariana Díaz Almirón, Alicia Herrero Ambrosio
7 October 2021